Page last updated: 2024-08-24

telmisartan and Adenocarcinoma

telmisartan has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Li, J; Liu, B; Yang, Y; Yu, P; Zhu, J	1
Chiyo, T; Fujihara, S; Iwama, H; Kato, K; Kobara, H; Masaki, T; Mori, H; Morishita, A; Ogawa, K; Tadokoro, T	1

Other Studies

2 other study(ies) available for telmisartan and Adenocarcinoma

Article	Year
Telmisartan exerts anti-tumor effects by activating peroxisome proliferator-activated receptor-γ in human lung adenocarcinoma A549 cells. Molecules (Basel, Switzerland), 2014, Mar-05, Volume: 19, Issue:3 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Benzimidazoles; Benzoates; Cell Line, Tumor; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Humans; Intercellular Adhesion Molecule-1; Lung Neoplasms; Matrix Metalloproteinase 9; PPAR gamma; RNA, Messenger; Telmisartan	2014
The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo. Oncotarget, 2017, Jan-31, Volume: 8, Issue:5 Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Antineoplastic Agents; Benzimidazoles; Benzoates; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; ErbB Receptors; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Phosphorylation; Receptor, ErbB-2; Signal Transduction; Telmisartan; Time Factors; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays	2017

Article

Year

Telmisartan exerts anti-tumor effects by activating peroxisome proliferator-activated receptor-γ in human lung adenocarcinoma A549 cells.

Molecules (Basel, Switzerland), 2014, Mar-05, Volume: 19, Issue:3

Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Benzimidazoles; Benzoates; Cell Line, Tumor; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Humans; Intercellular Adhesion Molecule-1; Lung Neoplasms; Matrix Metalloproteinase 9; PPAR gamma; RNA, Messenger; Telmisartan

2014

The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.

Oncotarget, 2017, Jan-31, Volume: 8, Issue:5

Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Antineoplastic Agents; Benzimidazoles; Benzoates; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; ErbB Receptors; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Phosphorylation; Receptor, ErbB-2; Signal Transduction; Telmisartan; Time Factors; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays

2017